Premium Vardenafil API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Vardenafil / Vardenafil Hydrochloride (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Phosphodiesterase Type 5 (PDE5) Inhibitor

Indications: Erectile Dysfunction (ED)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Vardenafil distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Vardenafil is a highly potent, orally active small-molecule Active Pharmaceutical Ingredient (API). In urological and reproductive pharmacology, it is classified as a selective phosphodiesterase type 5 (PDE5) inhibitor. For pharmaceutical manufacturers expanding their men's health portfolios, this API represents a highly effective, rapid-acting therapeutic option for the management of erectile dysfunction.

Pharmacologically, Vardenafil shares a similar structural and functional profile with other PDE5 inhibitors, but it is distinguished by its extreme biochemical potency. In vitro studies demonstrate that Vardenafil requires a significantly lower molar concentration to inhibit the PDE5 enzyme compared to legacy APIs like sildenafil.

At the physiological level, the API functions by competitively blocking the PDE5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. During sexual stimulation, the local release of nitric oxide (NO) stimulates the synthesis of cGMP. By preventing the breakdown of this nucleotide, Vardenafil sustains smooth muscle relaxation and facilitates increased arterial blood flow into penile tissues.

For pharmaceutical formulation scientists, integrating this API allows for the development of highly efficacious, low-dose oral therapeutics. In commercial manufacturing, this active ingredient is typically formulated into 5 mg, 10 mg, and 20 mg oral film-coated tablets or rapidly dissolving orally disintegrating tablets (ODTs).

Sourcing Vardenafil in Pakistan: Morgan’s Supply Network

Developing and commercializing urological formulations requires a highly resilient, traceable, and quality-assured raw material pipeline. Procuring specialty APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Vardenafil Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard pilot batch or are scaling up a high-volume Vardenafil api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during dry blending, wet granulation, and tablet compression processes.

Technical Specifications for QA & R&D

The Vardenafil API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 2-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one
• CAS Number: 224785-90-4 (Free Base) / 224789-15-5 (Hydrochloride Trihydrate)
• Appearance: White to off-white or slightly yellow crystalline solid powder
• Molecular Formula: C23H32N6O4S (Free Base)
• Molecular Weight: 488.6 g/mol (Free Base)
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers of varying pH levels are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and vehicle selection.

Manufacturing and Handling Guidelines for Formulators

While Vardenafil does not carry the severe teratogenic profiles of oncology or immunosuppressant drugs, it remains a highly potent pharmacologically active compound. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent chemical degradation.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, micronization, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.